Objectively Measured Hyperactivity—II. Caffeine and Amphetamine Effects

  title={Objectively Measured Hyperactivity—II. Caffeine and Amphetamine Effects},
  author={Martin D. Schechter and Gerald D. Timmons},
  journal={The Journal of Clinical Pharmacology},
Errors of commission and omission, chair movements, and reaction times were assessed in fifteen previously diagnosed hyperactive children on a Continuous Performance Test after four drug regimens: amphetamine at doses of 1.6 and 5.0 mg twice a day, as well as 300 mg caffeine administered alone and with 1.6 mg amphetamine twice a day, produced significant reductions in errors of commission and increased reaction times in those children scoring 24 or more on the Conner's Abbreviated Parent… 
Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine.
There is little evidence to suggest that methylxanthines have adverse cognitive or behavioral effects on children, and there was a small, positive effect on parental report of externalizing behavior for both theophylline and caffeine.
Ostracising caffeine from the pharmacological arsenal for attention-deficit hyperactivity disorder – was this a correct decision? A literature review
What is known of the effects of caffeine on symptoms and cognitive functions in attention-deficit hyperactivity disorder (ADHD) is considered, and the merits of investigating further caffeine’s therapeutic potential as a monotherapy or as an adjunctive agent in ADHD are considered.
Caffeine as an Independent Variable in Behavioral Research: Trends from the Literature Specific to ADHD
The focus of this review is not in evaluating the effectiveness of caffeine on ADHD, but rather to describe the experimental methods from which results were derived, including participants, preparation of caffeine, dose, methods of administration, dependent measures, and various experimental designs employed.
Effects of caffeine on cognitive, psychomotor, and affective performance of children with Attention-Deficit/Hyperactivity Disorder
Studies examining caffeine's effects on cognitive, psychomotor, and affective functioning of children with ADHD were reviewed. For children with ADHD, caffeine was more effective than no treatment in
Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) -- the spontaneously hypertensive rat (SHR).
A selective spatial learning deficit in SHR is demonstrated which can be attenuated by pre-training administration of caffeine, and the present findings indicate that the spatiallearning deficit inSHR is not directly related to hypertension.
Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence
The evidence strongly supports the use of stimulant medications for treating the core symptoms of children with ADHD and, to a lesser degree, for improving functioning.
Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder
This report summarizes the empirical literature on which the evidence strongly supports the use of stimulant medications for treating the core symptoms of children with ADHD and, to a lesser degree, for improving functioning.
This report summarizes the empirical literature on which the practice guideline’s recommendation for pharmacologic and/or behavioral intervention was based and indicates the use of stimulant medications for treating the core symptoms of children with ADHD and for improving functioning.
Marijuana, a Journey through the Endocannabinoid System: Unmasking the Paradoxical Effect - Part 1
This chapter explains the pathology of how cannabis consistently reacts in the ECS for every individual, implying that there was no found paradoxical effect existing in cannabis, but in the patient, and thus is perceived the same in every individual.


Acute effects of caffeine in normal prepubertal boys.
Caffeine produced increased vigilance and decreased reaction time, as does amphetamine, however, the higher dose of caffeine did not have a motor calming effect but increased motor activity.
The Effects of Caffeine on Hyperactive Children
Caffeine did not significantly improve reaction times and psychological test scores, but impulsivity and general behavior as measured by parent and teacher rating scales showed some significant improvements due to caffeine.
Methylphenidate and caffeine in the treatment of children with minimal brain dysfunction.
The tentative results of this study confirm the primary position of sympathomimetics in the pharmacotherapy of minimal brain dysfunction and suggest the involvement of dopamine pathways in this disorder.
Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: a double-blind comparison.
The authors compared the efficacy of caffeine, methylphenidate, and d-amphetamine in children with minimal brain dysfunction using a double-blind crossover design and found that both prescription drugs resulted in significant improvement and were significantly superior to caffeine.
Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.
One major difference between drugs was the apparently longer action of pemoline, since its effects at home and school tended to persist when the drug was withdrawn, whereas the patients receiving methylphenidate tended to regress to their baseline levels.
The effects of caffeine on reaction time in hyperkinetic and normal children.
: Using a double-blind design, the authors investigated 1) caffeine's effect in hyperkinetic children on a choice reaction time task, 2) whether caffeine has different effects on simple reaction time
Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
Double-blind crossover comparison of methylphenidate hydrochloride, dextroamphetamine sulfate, and caffeine after placebo washout in 29 children with minimal brain dysfunction (MBD) showed on six
Stimulant drug therapy in hyperactive children: research and clinical implications.
There is still some controversy over the effectiveness of stimulant drug use for children since it was first reported by Bradley, and several articles review the research in this area.
Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
Having reviewed what is known, what is only surmised, and what is not known about the psychopharmacology of stimulant drug use in children, the clinician must decide for which patient to use what